Back to dashboard
Low impact

Gene-Based Therapy for Duchenne Muscular Dystrophy (DMD) (CPB 0911, reviewed 2026-08-05)

Aetna·Medical Policy
Effective date
Not stated
We identified it
Aug 15, 2026
Days to comply
—

Related policy hubs